Cheng‐Tao Chang

1.2k total citations
34 papers, 863 citations indexed

About

Cheng‐Tao Chang is a scholar working on Psychiatry and Mental health, Surgery and Pharmacology. According to data from OpenAlex, Cheng‐Tao Chang has authored 34 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 6 papers in Surgery and 5 papers in Pharmacology. Recurrent topics in Cheng‐Tao Chang's work include Cellular Mechanics and Interactions (4 papers), Statistical Methods in Clinical Trials (4 papers) and Schizophrenia research and treatment (4 papers). Cheng‐Tao Chang is often cited by papers focused on Cellular Mechanics and Interactions (4 papers), Statistical Methods in Clinical Trials (4 papers) and Schizophrenia research and treatment (4 papers). Cheng‐Tao Chang collaborates with scholars based in United States, Taiwan and Japan. Cheng‐Tao Chang's co-authors include John Kattwinkel, Dennis Davidson, Michael C. Damask, Richard Straube, Elaine S. Barefield, Golde Dudell, Julio Rosenstock, Yizhen Xu, Eduard Montanya and Giorgio Sesti and has published in prestigious journals such as Diabetes Care, PEDIATRICS and Journal of Biomechanics.

In The Last Decade

Cheng‐Tao Chang

32 papers receiving 812 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheng‐Tao Chang United States 13 290 221 187 135 108 34 863
Rebecca E. Wrishko United States 16 140 0.5× 146 0.7× 193 1.0× 76 0.6× 95 0.9× 36 989
Andersson Ke Sweden 20 117 0.4× 157 0.7× 164 0.9× 73 0.5× 147 1.4× 48 1.1k
Tufan Tarcan Türkiye 24 280 1.0× 366 1.7× 278 1.5× 36 0.3× 101 0.9× 154 2.0k
Rex B. Shafer United States 22 177 0.6× 342 1.5× 267 1.4× 112 0.8× 191 1.8× 89 1.3k
Roser Ferrer Spain 18 171 0.6× 302 1.4× 241 1.3× 65 0.5× 97 0.9× 99 1.1k
Eberhard Barth Germany 16 157 0.5× 163 0.7× 146 0.8× 62 0.5× 149 1.4× 38 962
Soyhan Bağcı Germany 16 164 0.6× 184 0.8× 22 0.1× 98 0.7× 184 1.7× 69 860
Damian J. Mole United Kingdom 20 183 0.6× 448 2.0× 56 0.3× 28 0.2× 168 1.6× 59 1.1k
Tetsuya Nakagawa Japan 20 43 0.1× 108 0.5× 174 0.9× 117 0.9× 141 1.3× 79 1.1k
Margaret A. Kenny United States 16 77 0.3× 88 0.4× 107 0.6× 97 0.7× 147 1.4× 42 750

Countries citing papers authored by Cheng‐Tao Chang

Since Specialization
Citations

This map shows the geographic impact of Cheng‐Tao Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Tao Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Tao Chang more than expected).

Fields of papers citing papers by Cheng‐Tao Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐Tao Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Tao Chang. The network helps show where Cheng‐Tao Chang may publish in the future.

Co-authorship network of co-authors of Cheng‐Tao Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng‐Tao Chang. A scholar is included among the top collaborators of Cheng‐Tao Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng‐Tao Chang. Cheng‐Tao Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Craven, E. Randy, Vikás Chopra, Jeffrey L. Goldberg, et al.. (2022). Comparison of Iridocorneal Angle Assessments in Open-Angle Glaucoma and Ocular Hypertension Patients: Anterior Segment Optical Coherence Tomography and Gonioscopy. Clinical ophthalmology. Volume 16. 1301–1312. 3 indexed citations
2.
Chang, Cheng‐Tao, et al.. (2019). EFFECTS OF DIABETES MELLITUS ON VISCOELASTICITY OF ULTRASTRUCTURES OF PERIPHERAL NERVES: THREE-DIMENSIONAL FINITE ELEMENT ANALYSES. Journal of Mechanics in Medicine and Biology. 19(4). 1950022–1950022.
3.
Kornstein, Susan G., Cheng‐Tao Chang, Carl Gommoll, & John Edwards. (2018). Vilazodone efficacy in subgroups of patients with major depressive disorder. International Clinical Psychopharmacology. 33(4). 217–223. 8 indexed citations
4.
Findling, Robert L., Willie Earley, Trisha Suppes, et al.. (2018). Post hoc analyses of asenapine treatment in pediatric patients with bipolar I disorder: efficacy related to mixed or manic episode, stage of illness, and body weight. Neuropsychiatric Disease and Treatment. Volume 14. 1941–1952. 3 indexed citations
5.
Durgam, Suresh, Carl Gommoll, Raffaele Migliore, et al.. (2018). Relapse prevention in adults with major depressive disorder treated with vilazodone. International Clinical Psychopharmacology. 33(6). 304–311. 11 indexed citations
6.
Νitti, Victor W., Marcus J. Drake, Karel Everaert, et al.. (2017). Low Incidence of Clean Intermittent Catheterisation With OnabotulinumtoxinA in Diverse Age Groups of Overactive Bladder Patients With Corresponding Improvements in Urinary Symptoms, Treatment Response, and Quality of Life. Neurourology and Urodynamics. 1 indexed citations
7.
Thase, Michael E., John Edwards, Suresh Durgam, et al.. (2017). Effects of vilazodone on suicidal ideation and behavior in adults with major depressive disorder or generalized anxiety disorder. International Clinical Psychopharmacology. 32(5). 281–288. 11 indexed citations
8.
Citrome, Leslie, Ronald Landbloom, Cheng‐Tao Chang, & Willie Earley. (2017). Effects of asenapine on agitation and hostility in adults with acute manic or mixed episodes associated with bipolar I disorder. Neuropsychiatric Disease and Treatment. Volume 13. 2955–2963. 10 indexed citations
9.
10.
11.
Stoddard, Marcus F., et al.. (2002). Esmolol in acute ischemic syndromes. American Heart Journal. 144(5). E9–E9. 10 indexed citations
12.
Cooney, Gerard F., Stephen P. Dunn, John F. Sommerauer, et al.. (1999). Improved cyclosporine bioavailability in black pediatric liver transplant recipients after administration of the microemulsion formulation. Liver Transplantation and Surgery. 5(2). 112–118. 8 indexed citations
13.
Davidson, Dennis, Elaine S. Barefield, John Kattwinkel, et al.. (1999). Safety of Withdrawing Inhaled Nitric Oxide Therapy in Persistent Pulmonary Hypertension of the Newborn. PEDIATRICS. 104(2). 231–236. 65 indexed citations
14.
Davidson, Dennis, Elaine S. Barefield, John Kattwinkel, et al.. (1998). Inhaled Nitric Oxide for the Early Treatment of Persistent Pulmonary Hypertension of the Term Newborn: A Randomized, Double-Masked, Placebo-Controlled, Dose-Response, Multicenter Study. PEDIATRICS. 101(3). 325–334. 254 indexed citations
15.
Nedelman, Jerry, Jeffrey A. Cramer, Bruce A. Robbins, et al.. (1997). THE EFFECT OF FOOD ON THE PHARMACOKINETICS OF MULTIPLE-DOSE TERBINAFINE IN YOUNG AND ELDERLY HEALTHY SUBJECTS. Biopharmaceutics & Drug Disposition. 18(2). 127–138. 25 indexed citations
16.
Chang, Cheng‐Tao & Robert Wong. (1997). Assessment of Intrasubject Variability of Pharmacokinetic Parameters in Clinical Studies. Drug Information Journal. 31(4). 1203–1213. 2 indexed citations
17.
Schran, Horst, et al.. (1996). The Pharmacokinetics and Bioavailability of Clemastine and Phenylpropanolamine in Single‐Component and Combination Formulations. The Journal of Clinical Pharmacology. 36(10). 911–922. 27 indexed citations
18.
Robbins, Bruce A., et al.. (1996). Safe coadministration of terbinafine and terfenadine: A placebo-controlled crossover study of pharmacokinetic and pharmacodynamic interactions in healthy volunteers. Clinical Pharmacology & Therapeutics. 59(3). 275–283. 17 indexed citations
19.
Chang, Cheng‐Tao, Jerry Nedelman, Albert Cohen, et al.. (1995). Efficacy and Pharmacokinetics of Two Formulations of Cyclosporine A in Patients with Psoriasis. The Journal of Clinical Pharmacology. 35(9). 865–875. 31 indexed citations
20.
Nedelman, Jerry, Adel H. Karara, Cheng‐Tao Chang, et al.. (1995). INFERRING SYSTEMIC EXPOSURE FROM A PHARMACOKINETIC SCREEN: MODEL‐FREE AND MODEL‐BASED APPROACHES. Statistics in Medicine. 14(9). 955–968. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rebecca E. Wrishko Breakdown of academic impact, for papers by Andersson Ke Breakdown of academic impact, for papers by Tufan Tarcan Breakdown of academic impact, for papers by Rex B. Shafer Breakdown of academic impact, for papers by Roser Ferrer Breakdown of academic impact, for papers by Eberhard Barth Breakdown of academic impact, for papers by Soyhan Bağcı Breakdown of academic impact, for papers by Damian J. Mole Breakdown of academic impact, for papers by Tetsuya Nakagawa Breakdown of academic impact, for papers by Margaret A. Kenny
Rankless by CCL
2026